Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL · Alpha
██.█% Sign up free to reveal

Mesoblast Ltd (MESO) AI Forecast

Our AI analyzed Mesoblast Ltd. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$MESO Neutral Signal Full forecast available
Sign Up Free

Mesoblast Ltd (MESO) Stock Forecast Sept. 21, 2026

Mesoblast Ltd (MESO) AI Stock Price Forecast & Investment Analysis

Mesoblast Ltd Stock Price Chart and Technical Analysis

Loading chart...

Mesoblast Ltd (MESO) - Comprehensive Stock Analysis & Investment Research

Deep dive into Mesoblast Ltd's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on September 21, 2026 (UTC)

Mesoblast Ltd Investment Summary

When evaluating whether Mesoblast Ltd (MESO) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Mesoblast Ltd (MESO) operates within the Life Sciences sector, specifically in the Biological Products, (No Diagnostic Substances) industry. . With a market capitalization of $20 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Mesoblast Ltd's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Mesoblast Ltd along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Mesoblast Ltd is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Mesoblast Ltd

Sign Up Free
Corporate Identity

Mesoblast Ltd (Stock Symbol: MESO) is a prominent company operating within the Life Sciences sector, with a specific focus on the Biological Products, (No Diagnostic Substances) industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Mesoblast Ltd's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Mesoblast Ltd...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Mesoblast Ltd...

Unlock Full Company Profile

Get complete details about Mesoblast Ltd

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Mesoblast Ltd...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Mesoblast Ltd...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Mesoblast Ltd...

Unlock Financial Analysis

Get complete financial metrics for Mesoblast Ltd

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Mesoblast Ltd's AI Price Forecast

Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

4537 Stocks in the out-of-sample test
73.7% Rebalance periods with a positive net return
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Mesoblast Ltd strategically competes in the highly dynamic Biological Products, (No Diagnostic Substances) marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Mesoblast Ltd competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Financial Strength & Leverage

Mesoblast Ltd (MESO) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Mesoblast Ltd stock analysis. Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.

Deep dive into Mesoblast Ltd's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Mesoblast Ltd stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Mesoblast Ltd:

Market Cap $19.62B
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Mesoblast Ltd converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Mesoblast Ltd:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess Mesoblast Ltd's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Mesoblast Ltd:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Mesoblast Ltd's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Mesoblast Ltd:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Mesoblast Ltd uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Mesoblast Ltd:

Understanding Financial Statement Data

What these metrics mean: Key figures from Mesoblast Ltd's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Mesoblast Ltd:

Income Statement
Balance Sheet Highlights (USD millions)
Dividend & Shareholder Information
Shares Outstanding 1297M

Latest Mesoblast Ltd Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Mesoblast Ltd (MESO) stock price and investment outlook.

📰 Loading...

Where MESO sits on the market map

Explore the map →

Mesoblast Ltd Industry Peers - Biological Products, (No Diagnostic Substances)

Companies classified under the same SEC industry code as Mesoblast Ltd (Biological Products, (No Diagnostic Substances)): 60 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Company Ticker Symbol 90-Day AI Forecast (Alpha) Market Cap (USD M) P/E Ratio P/B Ratio
MESO ██% $19.62B x x
AMGN ██% $212.55B 24.3x 18.2x
GILD ██% $186.13B x 15.7x
MRNA ██% $61.50B x 9.1x
ARGX ██% $61.15B x x
RVMD ██% $40.93B x 15.7x
BIIB ██% $32.34B 23.6x 1.7x
BNTX ██% $24.78B x x
NBIX ██% $14.86B 21.1x 4.0x
EXEL ██% $14.18B x 7.7x
HALO ██% $12.76B 30.9x 88.9x
TECH ██% $11.35B 62.4x 5.4x
TWST ██% $10.47B x 23.5x
APGE ██% $10.22B x x
RGEN ██% $9.98B 240.3x 4.7x
KRYS ██% $9.97B 41.3x 7.3x
KYMR ██% $9.79B x 6.5x
QGEN ██% $9.40B x 2.5x
IBRX ██% $8.99B x x
PCVX ██% $8.65B x 3.1x
IMVT ██% $7.63B x 10.4x
CGON ██% $6.94B x 6.7x
SRRK ██% $5.68B x 22.4x
CRSP ██% $5.64B x 3.2x
IOVA ██% $4.64B x 6.3x
ADPT ██% $4.45B x 31.1x
RLAY ██% $4.13B x 4.6x
DBVT ██% $3.58B x 21.2x
TARS ██% $3.43B x 9.9x
DNLI ██% $3.27B x 3.9x
BEAM ██% $2.61B x 2.4x
BCRX ██% $2.24B x x
SCNI ██% $2.16B x 275.4x
ADMA ██% $2.13B 12.6x 5.2x
KOD ██% $2.06B x 33.7x
RXRX ██% $2.05B x 2.2x
VCEL ██% $2.05B 84.6x 5.5x
ALVO ██% $1.83B x x
VIR ██% $1.79B x 1.8x
COAG ██% $1.77B x 3.9x
NVAX ██% $1.67B x x
IMCR ██% $1.65B x 3.9x
TSHA ██% $1.64B x 4.2x
CGEM ██% $1.37B x 4.3x
MGTX ██% $1.27B 16.1x 5.9x
VOR ██% $1.27B x x
MAZE ██% $1.25B x 2.8x
REPL ██% $1.23B x 11.7x
JATT ██% $1.17B x 6.0x
ODTX ██% $1.17B x 2.8x
IMTX ██% $1.16B x x
VALN ██% $1.14B x x
GLUE ██% $1.03B x 2.1x
SLDB ██% $955M x 2.6x
SANA ██% $928M x 6.0x
CADL ██% $858M x 6.8x
FDMT ██% $841M x 2.1x
AURA ██% $660M x 2.1x
ALLO ██% $584M x 1.3x
PRME ██% $566M x 14.2x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Mesoblast Ltd Stock Forecast

How accurate are Mesoblast Ltd stock predictions?

A per-ticker accuracy statistic for MESO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

What factors influence Mesoblast Ltd stock price forecasts?

Our analysis considers Mesoblast Ltd's financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Mesoblast Ltd a good investment in 2026?

Based on our AI analysis, Mesoblast Ltd shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Mesoblast Ltd forecasts updated?

Mesoblast Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on September 21, 2026.

Want a simpler view of Mesoblast Ltd?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...